| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $52.2M | +416.6% |
| Cost of Revenue | $4.1M | +311.7% |
| R&D Expense | $35.2M | -61.4% |
| SG&A Expense | $76.6M | +5.9% |
| Operating Income | -$63.8M | +58.7% |
| Interest Expense | $3.4M | -24.5% |
| Pre-tax Income | -$67.2M | +57.5% |
| Income Tax | $8K | +100.0% |
| Net Income | -$67.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96.1M | +32.7% |
| Accounts Receivable | $7.7M | +1440.4% |
| Inventory | $28.3M | — |
| Current Assets | $153.6M | +14.9% |
| Total Assets | $190.1M | +26.8% |
| Current Liabilities | $65.6M | +24.2% |
| Long-term Debt | $26.7M | -17.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.0M | +54.1% |
| Capital Expenditures | $55K | -97.1% |
| Investing Cash Flow | $18.4M | -63.9% |
| Financing Cash Flow | $75.3M | -9.2% |
| Free Cash Flow | -$70.1M | +54.6% |
| +57.5% |
| EPS (Basic) | -$0.42 | +72.4% |
| EPS (Diluted) | -$0.42 | +72.4% |
| Total Liabilities |
| $91.7M |
| +36.3% |
| Stockholders' Equity | $98.3M | +19.0% |